D-0185-2025 Class II Ongoing
FDA drug recall D-0185-2025 was initiated by Eugia US LLC on Dec 18, 2024 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 19872 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 15, 2025
- Initiation Date
- Dec 18, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19872 vials
Product description
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the US
Code information
Lot No.: 1MP24069, Exp.: 08/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0185-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026